Neuroprotective effects of psychotropic drugs in Huntington's disease
about
Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's diseaseNeuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disordersSerotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.Dose-dependent protective effect of lithium chloride on retinal ganglion cells is interrelated with an upregulated intraretinal BDNF after optic nerve transection in adult rats.Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?BDNF-TrkB pathway mediates neuroprotection of hydrogen sulfide against formaldehyde-induced toxicity to PC12 cells.Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway.Hydrogen Sulfide Protects against Chronic Unpredictable Mild Stress-Induced Oxidative Stress in Hippocampus by Upregulation of BDNF-TrkB Pathway.Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification.Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.Epigenetic approaches for bipolar disorder drug discovery.Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development.Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosisLamotrigine Attenuates Proteasome Inhibition-Induced Apoptosis by Suppressing the Activation of the Mitochondrial Pathway and the Caspase-8- and Bid-Dependent Pathways.Antipsychotic drugs in Huntington's disease.MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?Lithium/Valproic acid combination and L-glutamate induce similar pattern of changes in the expression of miR-30a-5p in SH-SY5Y neuroblastoma cells.Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration.Regulation of P-glycoprotein expression in brain capillaries in Huntington's disease and its impact on brain availability of antipsychotic agents risperidone and paliperidone.Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic.A Novel Neuroprotective Mechanism for Lithium That Prevents Association of the p75NTR-Sortilin Receptor Complex and Attenuates proNGF-Induced Neuronal Death In Vitro and In Vivo.Sertraline, chlorprothixene, and chlorpromazine characteristically interact with the REST-binding site of the corepressor mSin3, showing medulloblastoma cell growth inhibitory activities
P2860
Q26748711-11DBED38-0B22-4D01-8E22-BB044F2CA454Q29396093-6B8CB79D-D71E-410D-AB34-63CF2AD6A65DQ30703360-2BD8EDC9-1FBC-433A-A779-83447A105E83Q34158396-6BD16C04-036C-4F40-9445-F6C5D20E6F15Q34284039-8C53EA49-B7A7-4721-9867-E8096797D0F3Q35573370-29BCC50B-C157-4151-A71D-386AD79C3EA1Q36150902-E3B55245-41EB-4169-A6A5-17D3352662C9Q37156906-DB99BB04-12CE-450F-BEC4-3E7E8290DCFBQ37548320-DD9A9A96-5881-4D02-9F10-E2058290AFA3Q37607467-CB306C72-BB13-4373-A6A4-3F4582DE88FAQ38215889-6D7AE29A-354E-4196-B03E-35BC72BD040EQ38246625-D1216E60-AD1F-482E-9AEF-E0215E16EA7EQ38717607-7A3D2F88-FA06-403F-8A6E-100C5768D941Q38768222-9651117D-35E2-45A2-B4C8-B39AF829F8E8Q38830416-9D8673EA-C7E2-4FF7-B6B4-3793567632CFQ38843644-9429E6CD-72F1-4270-925E-E15E96FC1352Q38963526-4CB0D74E-1D74-4B9E-B5A9-76F9AC606A64Q39008341-D618C081-6256-4C24-BE13-15532EBD5DEAQ42135650-91DB702D-487D-4062-8E37-1CDF81B901FBQ45298899-A3FB4527-BEC2-4E1B-9BEC-FC74DA1029FAQ47134235-5D099917-E262-443A-9A9A-A1AD057D575BQ47852679-9AD479AC-0FFB-4FAF-BBA0-AB5E1995A6CCQ58743854-69151B71-E7DF-40EC-B3AC-F56E56EE9427
P2860
Neuroprotective effects of psychotropic drugs in Huntington's disease
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Neuroprotective effects of psychotropic drugs in Huntington's disease
@en
type
label
Neuroprotective effects of psychotropic drugs in Huntington's disease
@en
prefLabel
Neuroprotective effects of psychotropic drugs in Huntington's disease
@en
P2860
P356
P1476
Neuroprotective effects of psychotropic drugs in Huntington's disease
@en
P2093
Edward C Lauterbach
P2860
P304
22558-22603
P356
10.3390/IJMS141122558
P407
P5008
P577
2013-11-15T00:00:00Z